Stock chart
Ticker: HOOK Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
Aug. 22, 2023 Aug. 21, 2023 B Purchase

Kandera Reinhard

Chief Financial Officer

Executive Director
7,000 +19.4%
0.73
5,075 USD
7,000 +19.4% 0.73 5,075 USD
Aug. 17, 2023 Aug. 16, 2023 B Purchase

Kandera Reinhard

Chief Financial Officer

Executive Director
8,000 +28.5%
0.71
5,712 USD
8,000 +28.5% 0.71 5,712 USD
July 11, 2023 July 11, 2023 B Purchase

Aldag Jorn

Chief Executive Officer

Executive Director
5,000 +7.5%
0.83
4,142 USD
5,000 +7.5% 0.83 4,142 USD
July 11, 2023 July 7, 2023 B Purchase

Aldag Jorn

Chief Executive Officer

Executive Director
5,000 +8.1%
0.81
4,050 USD
5,000 +8.1% 0.81 4,050 USD
July 7, 2023 July 5, 2023 B Purchase

Aldag Jorn

Chief Executive Officer

Executive Director
5,000 +8.8%
0.89
4,450 USD
5,000 +8.8% 0.89 4,450 USD
July 5, 2023 July 3, 2023 B Purchase

Aldag Jorn

Chief Executive Officer

Executive Director
5,000 +9.6%
0.89
4,456 USD
5,000 +9.6% 0.89 4,456 USD
July 3, 2023 June 30, 2023 B Purchase

Kandera Reinhard

Chief Financial Officer

Executive Director
12,000 +74.6%
0.88
10,560 USD
12,000 +74.6% 0.88 10,560 USD
Jan. 12, 2022 Dec. 21, 2021 S Sale

Matushansky Igor

Chief Medical Officer

Officer
2,205 -2.5%
2.49
5,490 USD
2,205 -2.5% 2.49 5,490 USD
Jan. 12, 2022 Dec. 21, 2021 S Sale

Matushansky Igor

Chief Medical Officer

Officer
7,440 -8.1%
2.49
18,526 USD
7,440 -8.1% 2.49 18,526 USD
Jan. 12, 2022 Dec. 21, 2021 S Sale

Matushansky Igor

Chief Medical Officer

Officer
5,304 -6.2%
2.49
13,207 USD
5,304 -6.2% 2.49 13,207 USD
April 23, 2021 April 21, 2021 S Sale

SOFINNOVA CAPITAL VI FCPR

Major owner
328,620 -9.4%
11.60
3,812,386 USD
328,620 -9.4% 11.60 3,812,386 USD
March 29, 2021 March 25, 2021 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
28,546 -0.8%
13.12
374,569 USD
28,546 -0.8% 13.12 374,569 USD
March 26, 2021 March 24, 2021 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
52,690 -1.4%
13.70
721,616 USD
52,690 -1.4% 13.70 721,616 USD
March 25, 2021 March 23, 2021 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
40,000 -1.1%
13.91
556,476 USD
40,000 -1.1% 13.91 556,476 USD
March 24, 2021 March 22, 2021 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
40,534 -1.1%
14.54
589,263 USD
40,534 -1.1% 14.54 589,263 USD
March 23, 2021 March 19, 2021 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
166,230 -4.3%
14.60
2,427,739 USD
166,230 -4.3% 14.60 2,427,739 USD
Dec. 18, 2020 Dec. 17, 2020 S Sale

Matushansky Igor

Chief Medical Officer

Officer
16,478 -17.6%
11.76
193,781 USD
16,478 -17.6% 11.76 193,781 USD
Dec. 18, 2020 Dec. 17, 2020 S Sale

Matushansky Igor

Chief Medical Officer

Officer
11,501 -15.2%
11.70
134,562 USD
11,501 -15.2% 11.70 134,562 USD
Dec. 18, 2020 Dec. 16, 2020 S Sale

Matushansky Igor

Chief Medical Officer

Officer
380 -0.7%
11.70
4,446 USD
380 -0.7% 11.70 4,446 USD
Oct. 6, 2020 Oct. 2, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
300 -0.0%
10.00
3,000 USD
300 -0.0% 10.00 3,000 USD
Sept. 17, 2020 Sept. 15, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
9,261 -0.2%
13.16
121,913 USD
9,261 -0.2% 13.16 121,913 USD
Sept. 17, 2020 Sept. 15, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
32,336 -0.8%
12.45
402,564 USD
32,336 -0.8% 12.45 402,564 USD
July 22, 2020 July 20, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
12,483 -0.3%
11.94
149,102 USD
12,483 -0.3% 11.94 149,102 USD
July 22, 2020 June 29, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
3,280 -0.1%
11.78
38,628 USD
3,280 -0.1% 11.78 38,628 USD
July 1, 2020 June 29, 2020 PS Planned sale

SOFINNOVA CAPITAL VI FCPR

Major owner
3,280 -0.1%
11.78
38,628 USD
3,280 -0.1% 11.78 38,628 USD
Jan. 31, 2020 Jan. 29, 2020 S Sale

Matushansky Igor

Chief Medical Officer

5,500 -9.3%
12.73
69,992 USD
5,500 -9.3% 12.73 69,992 USD
Jan. 27, 2020 Jan. 23, 2020 S Sale

Lilja Anders

Sr. VP, Technical Development

7,568 -100.0%
12.81
96,932 USD
7,568 -100.0% 12.81 96,932 USD
Jan. 27, 2020 Jan. 23, 2020 S Sale

Lilja Anders

Sr. VP, Technical Development

4,075 -100.0%
12.17
49,601 USD
4,075 -100.0% 12.17 49,601 USD
Jan. 21, 2020 Jan. 21, 2020 S Sale

Orlinger Klaus

Sr. VP, Research

6,789 -100.0%
12.02
81,592 USD
6,789 -100.0% 12.02 81,592 USD
Jan. 21, 2020 Jan. 16, 2020 S Sale

Orlinger Klaus

Sr. VP, Research

1,711 -100.0%
11.56
19,781 USD
1,711 -100.0% 11.56 19,781 USD
Jan. 16, 2020 Jan. 14, 2020 S Sale

Orlinger Klaus

Sr. VP, Research

8,500 -100.0%
11.30
96,053 USD
8,500 -100.0% 11.30 96,053 USD
Dec. 23, 2019 Dec. 19, 2019 S Sale

Matushansky Igor

Chief Medical Officer

Officer
10,404 -15.0%
9.93
103,312 USD
10,404 -15.0% 9.93 103,312 USD
Dec. 19, 2019 Dec. 17, 2019 S Sale

Matushansky Igor

Chief Medical Officer

Officer
11,484 -20.9%
7.87
90,379 USD
11,484 -20.9% 7.87 90,379 USD
April 25, 2019 April 23, 2019 B Purchase

Forbion Capital Fund II Cooperatief U.A.

Major owner
53,571 +2.2%
14.00
749,994 USD
53,571 +2.2% 14.00 749,994 USD
April 25, 2019 April 23, 2019 B Purchase

SOFINNOVA CAPITAL VI FCPR

Major owner
357,142 +9.9%
14.00
4,999,988 USD
357,142 +9.9% 14.00 4,999,988 USD
April 23, 2019 April 23, 2019 B Purchase

BAKER BROS. ADVISORS LP

Former 10% owner

820,729 +inf%
14.00
11,490,206 USD
820,729 +inf% 14.00 11,490,206 USD
April 23, 2019 April 23, 2019 B Purchase

BAKER BROS. ADVISORS LP

Former 10% owner

72,128 +inf%
14.00
1,009,792 USD
72,128 +inf% 14.00 1,009,792 USD